Cell Type develops models that simulate human drug response and analyze single-cell data for target selection and clinical design.
Cell Type's investors include Y Combinator, Pioneer Fund, Toloka.vc, ZAKA VC, SGH CAPITAL.
Cell Type is headquartered in San Francisco, United States.
Cell Type develops models that simulate human drug response and analyze single-cell data for target selection and clinical design.
Cell Type is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cell Type — Funding & Investors." VCBacked, April 14, 2026, https://www.vcbacked.co/company/cell-type. Accessed July 20, 2026.
VCBacked. (2026). Cell Type — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/cell-type
{{cite web |title=Cell Type — Funding & Investors |url=https://www.vcbacked.co/company/cell-type |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated